Trademark: 90674894
Word
LUXZYLA
Status
Pending
Status Code
688
Status Date
Tuesday, December 19, 2023
Serial Number
90674894
Mark Type
4000
Filing Date
Tuesday, April 27, 2021
Published for Opposition
Tuesday, October 24, 2023

Trademark Owner History
Cycle Pharmaceuticals Ltd. - Owner At Publication

Classifications
5 Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical agents for the treatment of lysosomal storage disorders and lysosomal storage diseases all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical agents for the treatment of Wilson's Disease; pharmaceutical agents for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceutical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of Wilson's Disease; pharmaceutical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases; pharmaceuticals for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of Wilson's Disease; pharmaceuticals for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary pharmaceutical preparations for treatment of disorders of the metabolism and digestive system; veterinary pharmaceutical preparations, namely, antioxidants; Veterinary pharmaceutical preparations, namely, pain relief medications; Veterinary pharmaceutical preparations for treatment of chronic illnesses; Veterinary pharmaceutical preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system; Dietary supplements for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Dietary supplements for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system; biological preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; biological preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of disorders of the metabolism and digestive system; chemical preparations for medical purposes, namely, for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; chemical preparations for medical purposes, namely, for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in pharmaceuticals; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of disorders of the metabolism and digestive system; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of lysosomal storage disorders and lysosomal storage diseases; drug delivery agents in the form of capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches for use in the treatment of Wilson's Disease; Pharmaceutical preparations in the form of drugs and medicines for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form drugs and medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form drugs and medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Pharmaceutical preparations in the form of drugs for the treatment of rare diseases, in particular for Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes; enzyme preparations for medical purposes for the treatment of disorders of the metabolism and digestive system; enzyme preparations for medical purposes the treatment of lysosomal storage disorders and lysosomal storage diseases; enzyme preparations for medical purposes the treatment of Wilson's Disease; medical enzyme preparations for medical purposes in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems; medical preparations for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medical preparations for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of lysosomal storage disorders and lysosomal storage diseases, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches medicines for the treatment of Wilson's Disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches
The wording "LUXZYLA" has no meaning in a foreign language.

Trademark Events
Dec 19, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 24, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 24, 2023
Published For Opposition
Oct 4, 2023
Notification Of Notice Of Publication E-Mailed
Sep 19, 2023
Approved For Pub - Principal Register
Aug 22, 2023
Teas/Email Correspondence Entered
Aug 22, 2023
Correspondence Received In Law Office
Aug 21, 2023
Assigned To Lie
Apr 7, 2023
Teas Request For Reconsideration Received
Oct 7, 2022
Notification Of Final Refusal Emailed
Oct 7, 2022
Final Refusal E-Mailed
Oct 7, 2022
Final Refusal Written
Jul 11, 2022
Assigned To Examiner
Jun 30, 2022
Teas/Email Correspondence Entered
Jun 30, 2022
Correspondence Received In Law Office
Jun 30, 2022
Teas Response To Office Action Received
Dec 30, 2021
Notification Of Non-Final Action E-Mailed
Dec 30, 2021
Non-Final Action E-Mailed
Dec 30, 2021
Non-Final Action Written
Dec 17, 2021
Assigned To Examiner
Aug 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2021
Teas Change Of Correspondence Received
Aug 5, 2021
Teas Change Of Owner Address Received
Aug 3, 2021
New Application Office Supplied Data Entered
Apr 30, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24